Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

4.15
Delayed Data
As of Sep 04
 +0.02 / +0.48%
Today’s Change
1.84
Today|||52-Week Range
12.80
-27.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues415.1K1.4M607.3K329.9K
 
 
 
 
 
Depreciation And Amortization78.0K76.6K38.6K87.9K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.8M4.8M3.9M3.1M
 
 
 
 
 
Research And Development2.1M2.8M1.6M1.6M
 
 
 
 
 
Total Operating Expenses3.9M4.8M3.9M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-3.5M-3.3M-2.9M
 
 
 
 
 
Extraordinary Credit--998.9K0.000.00
 
 
Extraordinary Charge-836.3K0.00-49.4K-1.5M
 
 
 
 
Pre-Tax Equity Earnings---285.5K-247.6K-114.6K
 
 
 
 
Interest Expense On Debt--78.9K446.4K81.4K
 
 
 
 
Other Expenses-340.6K13.5M356.3K65.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M10.7M-3.7M-4.5M
 
 
 
 
 
Minority Interest-519.5K-588.0K-48.2K-17.1K
 
 
 
 
 
Net Income-4.1M11.3M-3.7M-4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.9M2.9M3.2M4.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.9M2.9M3.2M4.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40$79.00-$1.14-$1.12
 
 
 
 
 
EPS Diluted-$1.40$3.95-$1.14-$1.12